metex pen 25 mg injektionsvæske, opløsning i fyldt pen
medac, gesellschaft für klinische spezialpräparate mbh - methotrexatnatrium - injektionsvæske, opløsning i fyldt pen - 25 mg
metex pen 27,5 mg injektionsvæske, opløsning i fyldt pen
medac, gesellschaft für klinische spezialpräparate mbh - methotrexatnatrium - injektionsvæske, opløsning i fyldt pen - 27,5 mg
metex pen 30 mg injektionsvæske, opløsning i fyldt pen
medac, gesellschaft für klinische spezialpräparate mbh - methotrexatnatrium - injektionsvæske, opløsning i fyldt pen - 30 mg
moviprep pulver til oral opløsning
paranova danmark a/s - kaliumchlorid, macrogol 3350, natriumchlorid - pulver til oral opløsning
mycophenolsyre "accord" 360 mg enterotabletter
accord healthcare b.v. - mycophenolatnatrium - enterotabletter - 360 mg
myfortic 360 mg enterotabletter
novartis healthcare a/s - mycophenolatnatrium - enterotabletter - 360 mg
daktarin 20 mg/g mundhulegel
2care4 aps - miconazol - mundhulegel - 20 mg/g
trilafon dekanoat 108,2 mg/ml injektionsvæske, opløsning, i.m.
orion corporation - perphenazindecanoat - injektionsvæske, opløsning, i.m. - 108,2 mg/ml
trilafon dekanoat 108,2 mg/ml injektionsvæske, opløsning, i.m.
orifarm a/s - perphenazindecanoat - injektionsvæske, opløsning, i.m. - 108,2 mg/ml
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrat, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.